CD1D and melanoma: Interestingly, CD1d-dependent cross-presentation by DC of GD3 derived from human melanoma cells was shown to activate cytokine responses in iNKT cells, suggesting mechanisms whereby CD1d-negative tumors may influence the antitumor immune response [20].